1. Academic Validation
  2. Structural modifications of indolinones bearing a pyrrole moiety and discovery of a multi-kinase inhibitor with potent antitumor activity

Structural modifications of indolinones bearing a pyrrole moiety and discovery of a multi-kinase inhibitor with potent antitumor activity

  • Bioorg Med Chem. 2020 Jun 1;28(11):115486. doi: 10.1016/j.bmc.2020.115486.
Mingze Qin 1 Ye Tian 2 Xiao Han 3 Qi Cao 2 Shuaishuai Zheng 2 Chunyang Liu 2 Xia Wu 2 Lei Liu 2 Yangyang Meng 2 Xiaobo Wang 4 Haotian Zhang 5 Yunlei Hou 6
Affiliations

Affiliations

  • 1 Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, PR China; Chinese People's Liberation Army Logistics Support Force No. 967 Hospital, Dalian 116021, PR China.
  • 2 Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, PR China.
  • 3 School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, PR China.
  • 4 Chinese People's Liberation Army Logistics Support Force No. 967 Hospital, Dalian 116021, PR China. Electronic address: wxbbenson0653@sina.com.
  • 5 Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, PR China. Electronic address: zhanghaotian2087@163.com.
  • 6 Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, PR China. Electronic address: houyunlei901202@163.com.
Abstract

Structural modifications of compound 2, an angiokinase inhibitor reported by our group were performed, which led to the discovery of methyl (Z)-3-(((4-(2-methyl-5-((4-methylpiperazin-1-yl)methyl)-1H-pyrrol-1-yl)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate (7h). Compound 7h exhibited excellent inhibitory activity against angiokinases including VEGFR-1/2/3, PDGFRα/β, and FGFR-1, as well as LYN and c-Kit kinases. At the cellular level, compound 7h significantly attenuated phosphorylation of Akt and ERK proteins, potently inhibited colony formation of HT-29, MKN74, and HepG2 Cancer cells, and induced cell Apoptosis. Upon incubation with human liver microsome, 7h exhibited comparable metabolic stability to nintedanib. Compound 7h has emerged as a promising lead compound for future drug design.

Keywords

Antitumor activity; Multi-kinase inhibitor; Structural modification.

Figures
Products